Adverse events should be reported. Reporting forms and information can be found at:

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.

For more information about Biquelle XL, please click here for the prescribing information.

Cost Saving

Up to 56% savings on the cost of category C quetiapine XL  prescriptions by prescribing Biquelle XL.2*

By prescribing Biquelle XL by brand, the average savings for a ICS/B could be more than £142,043 per year providing the NHS with a total potential annual prescribing cost saving of more than £8.7 million.**

Biquelle XL Cost Calculator

To find out how much you can save by prescribing Biquelle XL, please follow the instructions on the Biquelle XL calculator:

Biquelle XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • Up to 56% savings on Category C Drug Tariff prices;
  • Available from mainline wholesalers;
  • High level of stockholdings;
  • Price guaranteed until 2024***
  • Bioequivalent to the originator.3
Biquelle XL Quetiapine prolonged- tablets Category C Drug Tariff price (pack size 60) 1 Biquelle XL Price
Pack size 60 Pack size 30
50mg £67.66 £29.45 £14.73
150mg £113.10 £49.45 £24.73
200mg £113.10 £49.45 £24.73
300mg £170.00 £74.45 £37.23
400mg £226.20 £98.95 £49.48
600mg The only 600mg prolonged-release quetiapine tablets (pack size 30), priced at: £70.73 per month
*Based on 56% saving when prescribing Biquelle XL 50, 150, 200, 300 and 400mg tablets only, versus the cost of Category C quetiapine XL on the UK Drug Tariffs. ** Annual cost saving based on modelled market quarterly turnover data x 4 surrounding 42 ICS/ICBS reviewing their generic quetiapine prolonged-release tablet prescriptions to Biquelle XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariffs until the 2024 VPAS review.
References: 1) Insypher data: 10100831045 v 13.0 April 2023 CSC XL Range, GPPLPD Date Range: Sep-22 -Nov-22 MQT x4 2) UK Drug Tariffs (April 2023). 3) 1010067149 v 5.0 September 2021 Data on File – Bioequivalence for prolonged-release

More products available
in this range:
Click to view their
individual websites